Astronics Corporation (ATRO)
🔔 Watch stock
Astronics equips aircraft cabins with in-seat power, lighting and seat electronics — and lights up our in-house stock scanner 23 times at once, from the stage-2 trend to the Minervini trend template (scanner run as of July 17, 2026). We read the annual reports (10-K) and the quarterly report (10-Q) as of April 4, 2026: more revenue than in the old record year 2018, the first annual profit since 2019, a $734.3 million backlog — but also a 15-year patent war with Lufthansa Technik, $285.8 million spent buying back a convertible note issued just nine months earlier, and $11.9 million of cash next to $334.9 million of debt. Not investment advice — just the look into the logbook before you chase a stock that is already flying.
Appears in These Scanners
This stock currently matches 23 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Quality & Screener
AI Rating
NeutralGeprüft am 17.07.2026 gegen die Geschäftsberichte (10-K) 2025 (eingereicht 26.02.2026) und 2024 (05.03.2025) sowie die vier jüngsten Quartalsberichte (10-Q, zuletzt zum 04.04.2026): In den ausgewerteten SEC-Filings von Astronics findet sich kein wesentlicher KI-Bezug. Die 10-Ks nennen KI nur in Boilerplate-Passagen — als generisches Wettbewerbsrisiko („adapt more quickly than we do to new technologies, such as generative artificial intelligence (‚AI‘)“, Item 1A) und als Cybersecurity-/Datenschutz-Floskel zu KI-Tools bei Kunden und Zulieferern. Konkretester Treffer ist eine Lieferketten-Notiz im 10-K 2025, wonach KI-Ausgaben der Hyperscaler die Beschaffungsmärkte für Vorprodukte unter Druck setzen („Recent spending by hyperscalers and others to support AI is beginning to pressure supply chains for goods used to manufacture our products“) — ein Beschaffungskosten-Thema, weder KI-Umsatzquelle noch operativer KI-Einsatz noch konkretes KI-Risiko fürs eigene Geschäftsmodell (Kabinen-Elektronik und Testsysteme). Die vier 10-Q enthalten keinerlei KI-Treffer. Nach dem Kriterienkatalog: neutral.
View the full file — quotes, sources, reviewed filings
Filings Reviewed: 10-K 2026-02-26 · 10-K 2025-03-05 · 10-Q 2026-05-13 · 10-Q 2025-11-06 · 10-Q 2025-08-07 · 10-Q 2025-05-07
Rated on July 17, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.08 | -140.00 | 209 | 6.80 | -1.40 | 26 | 23 |
| 2025: Q1 | 0.22 | – | 206 | 11.30 | 4.60 | 21 | 19 |
| 2025: Q2 | 0.04 | -9.70 | 205 | 3.30 | 0.60 | -8 | -12 |
| 2025: Q3 | -0.31 | – | 211 | 3.80 | -5.20 | 35 | 22 |
| 2025: Q4 | 0.77 | – | 240 | 15.10 | 12.30 | 28 | 16 |
| 2026: Q1 | 0.67 | 201.30 | 231 | 12.00 | 11.10 | 11 | -1 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Assessment: Opportunities & Risks
2025 revenue of $862.1 million above the old 2018 peak for the first time, the first annual profit since 2019 ($29.4 million), Q1 2026 up 12 percent with a 16.5 percent Aerospace margin; book-to-bill of 1.26 and a $734.3 million backlog (quarterly report 10-Q as of 04/04/2026) — the recovery is not a price phenomenon, it is on the books.
23 hits in the in-house stock scanner in the momentum run of July 17, 2026 (stage 2, RS rating 95, Minervini trend template, power trend, institutional accumulation) alongside decent fundamentals (grade B, Piotroski 6/9) — a rare combination, but one that reads no court files.
Patent proceedings since December 2010; Germany lost with final effect on 02/25/2026 ($17.7 million reserved), $21.6 million already paid in the UK with the appeal scheduled for July 2026, France re-tries from 10/28/2026 — the 10-K itself calls further losses "probable" and potentially "substantial."
Repurchase of $132 million in principal of the company's own nine-month-old convertible for $285.8 million ($32.6 million book loss — more than the 2025 annual profit); only $11.9 million of cash next to $334.9 million of debt, and the zero-coupon 2031 note (conversion price $54.87) is already deep in the money with the stock around $87 — the same mechanism can get expensive again.
Roughly $3.1 billion of market value at 71 times trailing and roughly 39 times estimated current-year earnings (base: only three analysts; data as of July 17, 2026) — no bubble level for a turnaround with a full order book, but a price that already assumes the climb continues.
Astronics is a documented turnaround with momentum: record revenue, the first profit since 2019, a book-to-bill of 1.26 and 23 scanner hits. Against that stand a 15-year patent war with two court dates on the 2026 calendar, a cash position of just $11.9 million next to $334.9 million of debt, and a convertible mechanism that has already charged the rally $285.8 million once. At 71 times trailing earnings, the continuation of the climb is priced in — quiet landings are not. Not investment advice.
- ATRO reached the research list through the momentum/stage-2 scanner run of July 17, 2026, with 23 hits in the in-house stock scanner — attention here is a trend finding, not a fundamental verdict.
- Scanner metrics (RS rating, Piotroski, Altman Z, fundamental grade) are computed on trailing twelve-month figures; the $32.6 million loss from the convertible buyback (Q3 2025) is in them, potential further litigation costs naturally are not.
- Price and valuation figures dated July 17, 2026 (about $87, roughly $3.1 billion market value based on 35.7 million shares of both classes per the 10-K); analyses are evergreen, daily prices are not a buy argument. Astronics uses 13-week quarters (Q1 2026 ended April 4, 2026); the fiscal year ends December 31.
About the Company
Astronics Corporation entwirft und fertigt über ihre Tochtergesellschaften Produkte für die Branchen Luft- und Raumfahrt, Verteidigung und Elektronik in den USA, dem übrigen Nordamerika, Asien, Europa, Südamerika und international. Sie ist in zwei Segmenten tätig: Aerospace und Test Systems.
| Employees | 2,700 |
|---|---|
| Headquarters | East Aurora, NY |
| Website | astronics.com |
| IPO Date | 7. Sep 1984 |
| Next Earnings | 5. Aug 2026 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Peter J. Gundermann | Chairman, CEO & President | 1963 |
| Nancy L. Hedges | VP, CFO, Treasurer & Principal Accounting Officer | 1974 |
| Mark A. Peabody | Executive VP & President of Aerospace Segment | 1959 |
| James F. Mulato | Executive Vice President | 1961 |
| Julie M. Davis | General Counsel & Secretary | – |
| James S. Kramer | Executive VP & President of Luminescent Systems Inc. | 1964 |
| Michael C. Kuehn | Executive VP and President of Astronics Connectivity Systems & Certification Corp. | 1961 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.